Premature aging is a feature of the genetic disorder dyskeratosis congenita (DC). DC is caused by progressive shortening of telomeres, sequences that protect chromosome ends. Telomere shortening occurs in the normal process of aging, and mutations in telomerase, the enzyme that maintains telomere length, can accelerate this process. Although mouse models have provided insight into the role of telomeres in premature aging, they do not recapitulate all human symptoms. Here, María Cayuela’s group show that telomerase-deficient zebrafish demonstrate the hallmark features of premature aging in the first generation, in contrast with mice, which have to be bred for several generations. Intriguingly, the zebrafish mutants show ‘anticipation’ (onset of disease at a younger age in the next generation), which is also apparent in individuals with DC. Reintroduction of telomerase is able to rescue telomere length, confirming the importance of telomerase dosage and paving the way for studies of new therapeutics based on telomerase reactivation. Page 1101
- Written by editorial staff. © 2013. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly cited.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Editors’ choice – Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder
In our latest Editors' choice article, Katja M. Kanninen and colleagues examine neurogenesis in the neuronal ceroid lipofuscinoses – neurodegenerative disorders caused by loss of the Cln5 gene – and report a novel function of the CLN5 protein.
Call for papers: Cancer metabolism special collection
DEADLINE EXTENDED TO MONDAY 16TH OCTOBER 2016
DMM invites you to submit original research for a special collection focused on the dysregulation of metabolic pathways in cancer initiation, progression and resistance to treatment. This ongoing collection will be launched with a special issue scheduled for publication in spring 2018, with the special issue guest edited by Almut Schulze (University of Würzberg, Germany) and Mariia Yuneva (Crick Institute, London, UK).
Find out more here.
Review – Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
Richard P. Davis and colleagues review how human pluripotent stem cells have revolutionised the study of cardiac disease, highlighting their impact in investigating pathogenesis and their use in drug discovery, and look at current challenges facing the field.
First person – Lucía Zacchi
We continue our new series of interviews with the first authors of articles published in DMM, giving authors the opportunity to promote themselves alongside their papers. In this issue we feature Lucía Zacchi, first author on a Resource article describing a novel yeast screen to identify genetic modifiers of protein levels in dystonia.